MYL12A

Chr 18

myosin light chain 12A

Also known as: HEL-S-24, MLC-2B, MLCB, MRCL3, MRLC3, MYL2B

This gene encodes a myosin regulatory light chain that regulates smooth muscle and non-muscle cell contraction through phosphorylation and plays roles in cytokinesis and cell locomotion. Mutations cause autosomal dominant developmental and epileptic encephalopathy with onset in infancy, characterized by severe intellectual disability, refractory seizures, and movement disorders. The gene is not highly constrained against loss-of-function variants.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
136
P/LP submissions
P/LP missense
1.76
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMYL12A
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
131 unique Pathogenic / Likely Pathogenic· 32 VUS of 175 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.76LOEUF
pLI 0.001
Z-score 0.15
OE 0.93 (0.481.76)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.48Z-score
OE missense 0.58 (0.470.72)
56 obs / 96.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.93 (0.481.76)
00.351.4
Missense OE0.58 (0.470.72)
00.61.4
Synonymous OE0.89
01.21.6
LoF obs/exp: 5 / 5.4Missense obs/exp: 56 / 96.9Syn Z: 0.50
DN
0.82top 10%
GOF
0.75top 25%
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

175 submitted variants in ClinVar

Classification Summary

Pathogenic129
Likely Pathogenic2
VUS32
Benign1
Conflicting1
129
Pathogenic
2
Likely Pathogenic
32
VUS
1
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
129
Likely Pathogenic
2
VUS
32
Likely Benign
0
Benign
1
Conflicting
1
Total165

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MYL12A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found